Retrospective study comparing Micafungin with fluconazole or itraconazole as antifungal prophylaxis for patients undergoing haplo-identical allogeneic stem cell transplantation (haplo-SCT)

Micafungin, 50 mg/day administered intravenously, well-tolerated and effective against invasive fungal infection

Incidence of invasive aspergillosis and invasive fungal infections appears to be lower with micafungin though N of group was not large enough to be statistically significant